Barclays’s Achillion Pharmaceuticals ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-170,980
Closed -$1.03M 6725
2019
Q4
$1.03M Buy
170,980
+6,273
+4% +$36.3K ﹤0.01% 3649
2019
Q3
$593K Sell
164,707
-172
-0.1% -$663 ﹤0.01% 4108
2019
Q2
$442K Buy
164,879
+63,551
+63% +$188K ﹤0.01% 4428
2019
Q1
$300K Buy
101,328
+68,619
+210% +$169K ﹤0.01% 4528
2018
Q4
$51K Sell
32,709
-84,694
-72% -$239K ﹤0.01% 5469
2018
Q3
$432K Buy
117,403
+65,874
+128% +$196K ﹤0.01% 4397
2018
Q2
$146K Sell
51,529
-10,769
-17% -$36.7K ﹤0.01% 4990
2018
Q1
$230K Buy
62,298
+20,547
+49% +$67.2K ﹤0.01% 4711
2017
Q4
$119K Sell
41,751
-27,918
-40% -$101K ﹤0.01% 5111
2017
Q3
$313K Buy
69,669
+4,754
+7% +$21.1K ﹤0.01% 4042
2017
Q2
$297K Sell
64,915
-18,363
-22% -$73.8K ﹤0.01% 4017
2017
Q1
$351K Buy
83,278
+16,857
+25% +$70K ﹤0.01% 3756
2016
Q4
$274K Buy
66,421
+45,820
+222% +$244K ﹤0.01% 3931
2016
Q3
$167K Buy
+20,601
New +$175K ﹤0.01% 4121
2016
Q2
Sell
-16,440
Closed -$141K 6784
2016
Q1
$115K Sell
16,440
-60,976
-79% -$447K ﹤0.01% 4255
2015
Q4
$774K Sell
77,416
-39,352
-34% -$358K ﹤0.01% 2834
2015
Q3
$700K Sell
116,768
-109,361
-48% -$891K ﹤0.01% 3051
2015
Q2
$1.81M Buy
226,129
+157,656
+230% +$1.49M ﹤0.01% 2305
2015
Q1
$615K Sell
68,473
-250,375
-79% -$3.13M ﹤0.01% 3399
2014
Q4
$3.83M Sell
318,848
-92,142
-22% -$1.13M ﹤0.01% 1929
2014
Q3
$3.7M Buy
410,990
+203,918
+98% +$1.89M ﹤0.01% 2063
2014
Q2
$1.45M Buy
207,072
+116,150
+128% +$463K ﹤0.01% 2953
2014
Q1
$272K Buy
90,922
+48,017
+112% +$168K ﹤0.01% 4504
2013
Q4
$128K Sell
42,905
-131,763
-75% -$382K ﹤0.01% 5433
2013
Q3
$524K Buy
174,668
+54,850
+46% +$376K ﹤0.01% 4062
2013
Q2
$979K Buy
+119,818
New +$915K ﹤0.01% 3397